Received: 20 August 2020
Revised: 16 September 2020
Accepted: 13 October 2020
First Online: 26 October 2020
Compliance with ethical standards
: AM has received honoraria from Blueprint Medicines, Roche, and Incyte for invited lectures and receives research support from Janssen and Actuate Therapeutics.
Free to read: This content has been made available to all.